CSIMarket
 


Genetic Technologies Limited  (GENE)
Other Ticker:  
 

Cumulative Genetic Technologies Limited's Quick Ratio for Trailing Twelve Months Period

GENE's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

GENE Quick Ratio for Trailing Twelve Months Period

(Jun 30 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2018)
IV. Quarter
Y / Y Current Liabilities Growth 2.92 % 2.92 % 2.92 % 2.92 % -
Y / Y Cash & cash equivalent Growth -61.15 % -61.15 % -61.15 % -61.15 % -
Quick Ratio for Trailing Twelve Months Period 1.43 2 2.59 3.18 3.78
Total Ranking # # # # #
Seq. Current Liabilities Growth 0 % 0 % 0 % 2.92 % 0 %
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % -61.15 % 0 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to unchange in Current Liabilities in the IV. Quarter to $1 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 1.43 below Genetic Technologies Limited average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry Genetic Technologies Limited achieved highest Quick Ratio for Trailing Twelve Months Period. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about GENE
Quick Ratio GENE in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.43 1.43 1.43
(Jun 30 2019)  




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2019, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Cidara Therapeutics Inc   3.91 
Aerie Pharmaceuticals Inc   3.84 
Intuitive Surgical Inc   3.82 
Biontech Se  3.76 
Biondvax Pharmaceuticals Ltd   3.70 
Achieve Life Sciences Inc   3.63 
China Biologic Products Holdings Inc   3.53 
Quotient Limited  3.48 
Lineage Cell Therapeutics Inc   3.40 
Acorda Therapeutics inc   3.39 
Microbot Medical Inc   3.38 
Jounce Therapeutics inc   3.36 
Dbv Technologies S a   3.34 
Nanostring Technologies Inc   3.25 
Natural Health Trends Corp   3.23 
Sienna Biopharmaceuticals, Inc.  3.20 
Mymd Pharmaceuticals Inc   3.11 
Novavax inc   3.11 
Bionano Genomics Inc   3.05 
Trees Corporation  3.02 
Eyepoint Pharmaceuticals Inc   3.00 
Alpha Pro Tech Ltd   2.95 
Lifeloc Technologies Inc   2.92 
Cellular Biomedicine Group Inc   2.87 
Biomx Inc   2.86 
Pluri Inc   2.65 
Nanovibronix Inc  2.63 
Meridian Bioscience Inc   2.62 
Halozyme Therapeutics Inc   2.56 
Biofrontera Ag  2.50 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMFI's Profile

Stock Price

SMFI's Financials

Business Description

Fundamentals

Charts & Quotes

SMFI's News

Suppliers

SMFI's Competitors

Customers & Markets

Economic Indicators

SMFI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071